Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,026.00
Bid: 12,026.00
Ask: 12,028.00
Change: 38.00 (0.32%)
Spread: 2.00 (0.017%)
Open: 12,254.00
High: 12,256.00
Low: 12,020.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Cuts Travis Perkins To Underweight

Thu, 11th Aug 2016 08:35

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
BARCLAYS CUTS TRAVIS PERKINS TO 'UNDERWEIGHT' ('EQUALWEIGHT') - TARGET 1400 (1950) PENCE
----------
LIBERUM ADDS BRITISH LAND TO 'CONVICTION SELL LIST'
----------
COMMERZBANK CUTS EASYJET PRICE TARGET TO 1200 (1350) PENCE - 'HOLD'
----------
JPMORGAN CUTS RBS PRICE TARGET TO 175 (185) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS LLOYDS PRICE TARGET TO 62 (65) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BARCLAYS PRICE TARGET TO 175 (180) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ROLLS ROYCE GROUP PRICE TARGET TO 835 (730) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES PEARSON PRICE TARGET TO 935 (905) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES BHP BILLITON PRICE TARGET TO 900 (885) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 1378 (1324) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 5600 (5400) PENCE - 'BUY'
----------
HSBC CUTS ASTRAZENECA PRICE TARGET TO 4700 (4815) PENCE - 'HOLD'
----------
FTSE 250
----------
LIBERUM REMOVES TULLOW OIL FROM 'CONVICTION SELL LIST'
----------
PANMURE CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 168 (145) PENCE
----------
RBC CAPITAL RAISES CENTAMIN PRICE TARGET TO 190 (170) PENCE - 'SECTOR PERFORM'
----------
Numis Ups Centamin Target To 180p From 160p, Keeps Hold
----------
HSBC RAISES SEGRO PRICE TARGET TO 418 (378) PENCE - 'HOLD'
----------
HSBC CUTS BRITVIC PRICE TARGET TO 620 (640) PENCE - 'HOLD'
----------
Investec Ups Virgin Money Target To 375p From 360p, Keeps Buy
----------
Cantor Cuts Debenhams Target To 60p From 70p, Keeps Hold
----------
Liberum Ups Spirax-Sarco Target To 4,090p From 3,140p, Keeps Hold
----------
MORGAN STANLEY RAISES SPIRAX-SARCO TARGET TO 4080 (3570) PENCE - 'EQUAL-WEIGHT'
----------
S&P GLOBAL RAISES AMEC PRICE TARGET TO 600 (500) PENCE - 'BUY'
----------
TRADERS: CANACCORD CUTS ENTERTAINMENT ONE TO 'HOLD' ('BUY')
----------
BERENBERG RAISES INMARSAT PRICE TARGET TO 910 (880) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
RBC CAPITAL CUTS FAROE PETROLEUM PRICE TARGET TO 100 (120) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES INTERSERVE PRICE TARGET TO 425 (416) PENCE - 'OVERWEIGHT'
----------
finnCap Initiates Joules Group With Buy, Target At 200p
----------
Berenberg Ups Benchmark Holdings Target To 80p From 70p, Keeps Buy
----------
BERENBERG RAISES STOCK SPIRITS PRICE TARGET TO 150 (137) PENCE - 'HOLD'
----------
BERENBERG CUTS LOOKERS PRICE TARGET TO 170 (220) PENCE - 'BUY'
----------
BERENBERG RAISES GVC HOLDING PRICE TARGET TO 760 (730) PENCE - 'BUY'
----------
BERENBERG RAISES STAFFLINE TO 'BUY' ('HOLD') - TARGET 1250 (900) PENCE
----------
Numis Ups Breedon Aggregates to Add From Hold, Target To 82p From 70p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.